PNS Pharma

PNS Pharma is a pioneer in offering exclusive research reports for the pharmaceuticals industry. The research reports provide a deep analysis of the current trends in the space of drug development and various therapeutic areas. These reports deliver significant benefits to clients and other healthcare professional to enable them to identify investment opportunity in the companies with a strong drug pipeline.

A broad range of therapeutic categories – including cardiovascular, diabetes and endocrinology, neurosciences and ophthalmology, oncology, infectious diseases, and respiratory and immunology is covered. Each therapeutic category includes all activities from research and development, new drugs, analysis on existing drug profile and strategic market analysis.

PNS Pharma offers Syndicated Research Reports including Drug Pipeline and Company Pipeline Analysis. The reports analyzing drug pipeline include sections on all the available information related to the introduction and development of various drugs being developed in the market. Further, the reports include details on the originator, Owner, License, Chemical Formula, Patent Information, Phase of development, and Phase of development by country for each specific drug. The reports on company pipeline include all the drugs developed by particular companies across different therapeutic segments and phases and in different countries.
The syndicated reports from PNS Pharma would enable the clients to easily assess the opportunities and risks influencing different therapy markets, satisfy the unmet needs in the treatment of certain diseases and trends in the current development. The clients would be able to obtain an impartial perspective of the strategies used between competing companies involved in the pipeline to enhance their product's performance.


Research Reports By PNS Pharma

Found 42 publications
US CNS Disorders Drug Pipeline Insight 2014 US$ 2,400.00 Aug, 2014 1700 pages
US Orphan Drug Clinical Pipeline Insight 2014 US$ 2,000.00 Aug, 2014 2000 pages
Cancer Cytokines Therapy Pipeline Analysis US$ 1,800.00 Jun, 2014 231 pages
Schizophrenia Drug Market & Pipeline Insight US$ 1,200.00 Jun, 2014 386 pages
Cervical Cancer Drug Market & Pipeline Insight US$ 1,200.00 Jun, 2014 165 pages
Crohn’s Disease Drug Market and Pipeline Analysis US$ 1,800.00 May, 2014 297 pages
Global Peptide Therapeutics Market & Pipeline Insight US$ 2,400.00 Feb, 2014 1350 pages
Europe Orphan Drug Pipeline Analysis 2014 US$ 2,400.00 Jan, 2014 1430 pages
Global Monoclonal Antibodies Pipeline Analysis US$ 1,800.00 Jan, 2014 1360 pages
Europe Lung Cancer Drug Pipeline Analysis US$ 1,200.00 Jan, 2014 340 pages
US Cancer Vaccine Pipeline Analysis US$ 1,500.00 Jan, 2014 300 pages
Japan Cancer Drug Pipeline Analysis US$ 1,500.00 Jan, 2014 557 pages
Europe Alzheimer's Disease Drug Pipeline Analysis US$ 1,500.00 Jan, 2014 265 pages
US Skin Cancer Drug Pipeline Analysis US$ 1,200.00 Jan, 2014 310 pages
Global Vaccine Market Pipeline Analysis US$ 1,500.00 Jan, 2014 1150 pages
Europe Parkinson’s Disease Drug Pipeline Analysis US$ 1,000.00 Jan, 2014 199 pages
Global Orphan Drug Pipeline Analysis US$ 2,400.00 Dec, 2013 1690 pages
US Parkinson's Disease Drug Pipeline Analysis US$ 1,500.00 Nov, 2013 241 pages
US Colorectal Cancer Drug Pipeline Analysis US$ 1,500.00 Nov, 2013 242 pages
US Lung Cancer Drug Pipeline Analysis US$ 1,800.00 Nov, 2013 385 pages
US Prostate Cancer Drug Pipeline Analysis US$ 1,800.00 Oct, 2013 375 pages
Global Oncolytic Virus Therapy Pipeline Analysis US$ 1,500.00 Oct, 2013 105 pages
US Alzheimer Drug Pipeline Analysis US$ 2,000.00 Oct, 2013 348 pages
US Orphan Drug Pipeline Analysis US$ 1,800.00 Oct, 2013 880 pages
Global HIV Infection Drug Pipeline Analysis US$ 1,500.00 Oct, 2013 300 pages
Global DNA Vaccine Pipeline Analysis US$ 1,500.00 Oct, 2013 130 pages
Europe Breast Cancer Drug Pipeline Analysis US$ 1,800.00 Oct, 2013 380 pages
Orphan Drugs for Cancer Pipeline Analysis US$ 1,800.00 Oct, 2013 855 pages
Global RNAi Drug Pipeline Analysis US$ 1,500.00 Oct, 2013 250 pages
US Breast Cancer Drug Pipeline Analysis US$ 1,800.00 Oct, 2013 480 pages
Global Infertility Drug Pipeline Analysis US$ 1,000.00 Oct, 2013 60 pages
Global Cancer Vaccines Pipeline Analysis US$ 1,800.00 Sep, 2013 345 pages
Gene Therapy Drug Pipeline Analysis US$ 1,500.00 Sep, 2013 185 pages
Global Cell Therapy Pipeline Analysis US$ 1,500.00 Sep, 2013 220 pages
Malaria Disease Drug Pipeline Analysis US$ 1,200.00 Aug, 2013 185 pages
Europe Orphan Drugs Pipeline Analysis US$ 2,400.00 Aug, 2013 1300 pages
Hepatitis C Drug Pipeline Analysis US$ 1,800.00 Aug, 2013 700 pages
Pancreatic Cancer Drug Pipeline Analysis US$ 1,800.00 Aug, 2013 515 pages
Ovarian Cancer Pipeline Analysis US$ 1,800.00 Aug, 2013 660 pages
Skip to top

News & Press-Releases by PNS Pharma